Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityOther Non-Current LiabilitiesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Goldenwell Biotech (GWLL) Current Leases (2021 - 2022)

Goldenwell Biotech's Current Leases history spans 2 years, with the latest figure at $25372.0 for Q4 2022.

  • For Q4 2022, Current Leases fell 46.9% year-over-year to $25372.0; the TTM value through Dec 2022 reached $25372.0, down 46.9%, while the annual FY2022 figure was $25372.0, 46.9% down from the prior year.
  • Current Leases reached $25372.0 in Q4 2022 per GWLL's latest filing, down from $29126.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $47779.0 in Q4 2021 to a low of $17069.0 in Q1 2021.